223 related articles for article (PubMed ID: 33051202)
1. Co-crystal structures of HIV TAR RNA bound to lab-evolved proteins show key roles for arginine relevant to the design of cyclic peptide TAR inhibitors.
Chavali SS; Mali SM; Jenkins JL; Fasan R; Wedekind JE
J Biol Chem; 2020 Dec; 295(49):16470-16486. PubMed ID: 33051202
[TBL] [Abstract][Full Text] [Related]
2. Cyclic peptides with a distinct arginine-fork motif recognize the HIV trans-activation response RNA in vitro and in cells.
Chavali SS; Mali SM; Bonn R; Saseendran Anitha A; Bennett RP; Smith HC; Fasan R; Wedekind JE
J Biol Chem; 2021 Dec; 297(6):101390. PubMed ID: 34767799
[TBL] [Abstract][Full Text] [Related]
3. The interactions and recognition of cyclic peptide mimetics of Tat with HIV-1 TAR RNA: a molecular dynamics simulation study.
Li CH; Zuo ZC; Su JG; Xu XJ; Wang CX
J Biomol Struct Dyn; 2013 Mar; 31(3):276-87. PubMed ID: 22943434
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous recognition of HIV-1 TAR RNA bulge and loop sequences by cyclic peptide mimics of Tat protein.
Davidson A; Leeper TC; Athanassiou Z; Patora-Komisarska K; Karn J; Robinson JA; Varani G
Proc Natl Acad Sci U S A; 2009 Jul; 106(29):11931-6. PubMed ID: 19584251
[TBL] [Abstract][Full Text] [Related]
5. Structure of HIV TAR in complex with a Lab-Evolved RRM provides insight into duplex RNA recognition and synthesis of a constrained peptide that impairs transcription.
Belashov IA; Crawford DW; Cavender CE; Dai P; Beardslee PC; Mathews DH; Pentelute BL; McNaughton BR; Wedekind JE
Nucleic Acids Res; 2018 Jul; 46(13):6401-6415. PubMed ID: 29961805
[TBL] [Abstract][Full Text] [Related]
6. Interaction of human immunodeficiency virus type 1 Tat-derived peptides with TAR RNA.
Long KS; Crothers DM
Biochemistry; 1995 Jul; 34(27):8885-95. PubMed ID: 7612630
[TBL] [Abstract][Full Text] [Related]
7. Face-time with TAR: Portraits of an HIV-1 RNA with diverse modes of effector recognition relevant for drug discovery.
Chavali SS; Bonn-Breach R; Wedekind JE
J Biol Chem; 2019 Jun; 294(24):9326-9341. PubMed ID: 31080171
[TBL] [Abstract][Full Text] [Related]
8. Discoveries of Tat-TAR interaction inhibitors for HIV-1.
Yang M
Curr Drug Targets Infect Disord; 2005 Dec; 5(4):433-44. PubMed ID: 16535863
[TBL] [Abstract][Full Text] [Related]
9. How binding of small molecule and peptide ligands to HIV-1 TAR alters the RNA motional landscape.
Bardaro MF; Shajani Z; Patora-Komisarska K; Robinson JA; Varani G
Nucleic Acids Res; 2009 Apr; 37(5):1529-40. PubMed ID: 19139066
[TBL] [Abstract][Full Text] [Related]
10. Selection of TAR RNA-binding chameleon peptides by using a retroviral replication system.
Xie B; Calabro V; Wainberg MA; Frankel AD
J Virol; 2004 Feb; 78(3):1456-63. PubMed ID: 14722301
[TBL] [Abstract][Full Text] [Related]
11. A Cyclic Mimic of HIV Tat Differentiates Similar TAR RNAs on the Basis of Distinct Dynamic Behaviors.
Lu J; Nguyen L; Zhao L; Xia T; Qi X
Biochemistry; 2015 Jun; 54(23):3687-93. PubMed ID: 26016940
[TBL] [Abstract][Full Text] [Related]
12. Specific HIV-1 TAR RNA loop sequence and functional groups are required for human cyclin T1-Tat-TAR ternary complex formation.
Richter S; Cao H; Rana TM
Biochemistry; 2002 May; 41(20):6391-7. PubMed ID: 12009901
[TBL] [Abstract][Full Text] [Related]
13. Binding of a cyclic BIV beta-Tat peptide with its TAR RNA construct.
Tok JB; Des Jean RC; Fenker J
Bioorg Med Chem Lett; 2001 Jan; 11(1):43-6. PubMed ID: 11140729
[TBL] [Abstract][Full Text] [Related]
14. Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots".
Davis B; Afshar M; Varani G; Murchie AI; Karn J; Lentzen G; Drysdale M; Bower J; Potter AJ; Starkey ID; Swarbrick T; Aboul-ela F
J Mol Biol; 2004 Feb; 336(2):343-56. PubMed ID: 14757049
[TBL] [Abstract][Full Text] [Related]
15. Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition.
Calnan BJ; Biancalana S; Hudson D; Frankel AD
Genes Dev; 1991 Feb; 5(2):201-10. PubMed ID: 1899841
[TBL] [Abstract][Full Text] [Related]
16. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA.
Garber ME; Mayall TP; Suess EM; Meisenhelder J; Thompson NE; Jones KA
Mol Cell Biol; 2000 Sep; 20(18):6958-69. PubMed ID: 10958691
[TBL] [Abstract][Full Text] [Related]
17. Probing the proximity of the core domain of an HIV-1 Tat fragment in a Tat-TAR complex by affinity cleaving.
Huq I; Rana TM
Biochemistry; 1997 Oct; 36(41):12592-9. PubMed ID: 9376365
[TBL] [Abstract][Full Text] [Related]
18. Structural mechanism for HIV-1 TAR loop recognition by Tat and the super elongation complex.
Schulze-Gahmen U; Hurley JH
Proc Natl Acad Sci U S A; 2018 Dec; 115(51):12973-12978. PubMed ID: 30514815
[TBL] [Abstract][Full Text] [Related]
19. Essential structural requirements for specific recognition of HIV TAR RNA by peptide mimetics of Tat protein.
Davidson A; Patora-Komisarska K; Robinson JA; Varani G
Nucleic Acids Res; 2011 Jan; 39(1):248-56. PubMed ID: 20724442
[TBL] [Abstract][Full Text] [Related]
20. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185.
Wu F; Garcia J; Sigman D; Gaynor R
Genes Dev; 1991 Nov; 5(11):2128-40. PubMed ID: 1936997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
